Related Experiment Video

Updated: Feb 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

[An Uncommon Case of Pneumonia]

J A von Donat1, M Weber2

  • 1Städtische Kliniken Mönchengladbach GmbH, Elisabeth-Krankenhaus Rheydt, Medizinische Klinik, Mönchengladbach.

Pneumologie (Stuttgart, Germany)
|December 7, 2017
PubMed

Insights

Pneumocystis jirovecii pneumonia typically affects immunocompromised individuals. This report details a rare case in an immunocompetent patient, exploring potential causes for this unusual presentation.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Immunology

Background:

  • Pneumocystis jirovecii pneumonia (PJP) is a significant opportunistic infection.
  • It predominantly affects individuals with compromised immune systems, such as those with HIV/AIDS or undergoing immunosuppressive therapy.

Observation:

  • This case study presents a PJP infection in a patient who is HIV-negative and immunocompetent.
  • The patient exhibited symptoms consistent with PJP, necessitating diagnostic investigation.

Findings:

  • The diagnosis of PJP was confirmed despite the absence of typical risk factors.
  • The report discusses potential, less common etiologies for PJP in this specific patient profile.

Implications:

  • This case highlights the importance of considering PJP even in immunocompetent individuals presenting with respiratory symptoms.
  • It expands the understanding of PJP's potential hosts and broadens differential diagnoses for respiratory illnesses.
  • Further research into non-HIV-related PJP risk factors may be warranted.

More Related Videos

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.3K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.2K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
945
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
934
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
838
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.5K